AIS's Health Business Daily is a daily email newsletter with strategic business stories written by senior AIS reporters, as well as quick-and-easy news bites of interest to health care business leaders. Subscribe now to get an issue delivered to your inbox every morning!
Medicare Advantage News
Today’s issue is brought to you by AIS's Medicare Advantage News, biweekly news and analysis on the Medicare (and Medicaid) managed care programs. Sign up for an $87 two-month trial subscription today.

December 6, 2016

Today's Featured Story

Trump Victory Raises Big Questions for Medicaid Expansion, Medicare Advantage Insurers
Reprinted from Medicare Advantage News

Donald Trump’s shocking victory on Nov. 8 will spell big changes for all facets of the health care industry, as the president-elect and congressional Republicans — which retained control of both the House and Senate — are expected to repeal much of the Affordable Care Act (ACA). And though many aspects of health reform remain up in the air, industry observers agree that the likely transition to block-granting in Medicaid will give states the flexibility they’ve long desired, while changes to the Medicare Advantage program — which could include payment reform and a shift to “premium support” — may take longer to materialize.... Read Full Story


Quote of the Day

“The likelihood of significant drug pricing reforms decreases [under the Trump Administration], but is not eliminated, based on the election outcome. Public concern about drug prices is strong, so there will still be pressure to explore policy changes that can address concerns over drug prices. Those policy options are more likely to focus on market driven, competitive solutions rather than proposals that seek to externally gap prices or explicitly limit company profits. Defeat of the California drug pricing ballot initiative is a major victory for the [pharmaceutical] industry and may discourage similar efforts in other states. However, state emphasis on increasing transparency on drug prices could persist in 2017.”

— Caroline Pearson, senior vice president, policy and strategy, Avalere Health, told AIS’s Drug Benefit News.

Click here to read the DRUG BENEFIT NEWS article in which this quote appeared — "How Will Trump Presidency Impact Drug Prices, Rx Benefits, ACA, Biosimilars? " (Free for DBN subscribers; $17 for non-subscribers.)


Today's Datapoint

5.4% ... was the growth in national health spending in the year that ended September 2016, according to the Altarum Institute.



Today from Washington

People on the Move

Capital BlueCross appointed Jack Jaroh senior vice president of commercial group sales. Jaroh previously was vice president of client management at Highmark Blue Shield....The Senior Care Pharmacy Coalition named Phil Fogg, Jr., chairman. Fogg is currently the chairman and CEO of Marquis Companies and Consonus Health Care....Avanir Pharmaceuticals, Inc. named Richard Malamut, M.D., senior vice president, research and development, and chief medical officer. Prior to Avanir, he was the senior vice president of global clinical development at Teva Pharmaceutical Industries Ltd.


The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Content questions or suggestions should be directed to Executive Editor Jill Brown at If you are interested in advertising in AIS's HEALTH BUSINESS DAILY, please contact BJ Taylor at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2016 Atlantic Information Services, Inc. (AIS). All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to

With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)

AISHealth  Follow AISHealth on Twitter  Follow AISHealth on Facebook  Follow AISHealth on LinkedIn